NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)

Ceiling: $150,000
Applications Due: Closed
Federal
US Department of Health & Human Services (National Institutes of Health)

This grant provides funding to research teams for planning clinical trials focused on innovative regenerative medicine approaches to restore vision, including developing protocols and addressing regulatory requirements.

Description

The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research specifically targets photoreceptors (PRCs) and retinal ganglion cells (RGCs) in the eye. Photoreceptors often called rods and cones are cells in the retina that, when stimulated by light, generate signals the brain perceives as images. The retinal ganglion cells carry these signals from the photoreceptors to the brain. Although there has been some success in regenerating retinal neurons and connections in fish, mice, and other systems, the ultimate goal of the AGI is to restore vision in humans.

Eligibility

States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Native American tribal organizations, Nonprofits

Funding

Program Funding
Award Ceiling
$150,000
Award Floor
Award Count

Timing

Posted Date
March 08, 2022
App Status
No Longer Accepting Applications
Pre-app Deadline
Application Deadline
December 19, 2024

Funder

Funding Source
Source Type
Federal
Contact Name
NIH OER Webmaster
Contact Email
Contact Phone
--

Why Organizations Trust GrantExec

$78.81B
Available Funding
7,151
Active Grants
224
New Grants Analyzed This Week